This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2026 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.94% per year. These returns cover a period from January 1, 1988 through July 6, 2026. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View the Zacks #1 Rank List
moving-average-crossover: Archive
New Mountain (NMFC) Soars 5.0%: Is Further Upside Left in the Stock?
by Zacks Equity Research
New Mountain (NMFC) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
NMFCNegative Net Change NCDLNegative Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
Universal Display (OLED) Moves 3.0% Higher: Will This Strength Last?
by Zacks Equity Research
Universal Display (OLED) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
OLEDNegative Net Change VICRPositive Net Change
momentum-stocks moving-average-crossover price-performance stock-price-movement stocks-moving-today
Yext (YEXT) Soars 14.3%: Is Further Upside Left in the Stock?
by Zacks Equity Research
Yext (YEXT) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
YEXTNegative Net Change BTBTPositive Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
Nektar (NKTR) Soars 51.1%: Is Further Upside Left in the Stock?
by Zacks Equity Research
Nektar (NKTR) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
NKTRNegative Net Change MKKGYNegative Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
Sutro Biopharma (STRO) Surges 11.9%: Is This an Indication of Further Gains?
by Zacks Equity Research
Sutro Biopharma (STRO) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
STROPositive Net Change TCRXPositive Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
Axon (AXON) Stock Jumps 3%: Will It Continue to Soar?
by Zacks Equity Research
Axon (AXON) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
AXONNegative Net Change EADSYNegative Net Change
momentum-stocks moving-average-crossover price-performance stock-price-movement stocks-moving-today
Credo Technology Group (CRDO) Soars 9.2%: Is Further Upside Left in the Stock?
by Zacks Equity Research
Credo Technology Group (CRDO) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
CRDOPositive Net Change QUIKNegative Net Change
momentum-stocks moving-average-crossover price-performance stock-price-movement stocks-moving-today
Ultra Clean (UCTT) Moves 7.0% Higher: Will This Strength Last?
by Zacks Equity Research
Ultra Clean (UCTT) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
UCTTPositive Net Change ACLSPositive Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
W&T Offshore (WTI) Just Flashed Golden Cross Signal: Do You Buy?
by Zacks Equity Research
Is it a good or bad thing when a stock experiences a golden cross technical event?
WTIPositive Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Iamgold (IAG) Recently Broke Out Above the 20-Day Moving Average
by Zacks Equity Research
When a stock breaks out above the 20-day simple moving average, good things could be on the horizon. How should investors react?
IAGPositive Net Change
daily-movers moving-average-crossover stocks-moving-today